Trump again says he is considering reclassifying marijuana as less dangerous drug

Core Viewpoint - President Trump is considering reclassifying marijuana from a Schedule I to a Schedule III drug, which could significantly impact the cannabis industry and research opportunities [1][6][10]. Industry Impact - Reclassifying marijuana as a Schedule III drug would ease the buying and selling of cannabis, potentially increasing profitability for the cannabis industry [6][7]. - The reclassification would lower barriers to research, allowing for more extensive studies on marijuana [2][6]. - Cannabis stocks surged following reports of Trump's consideration to ease federal restrictions on marijuana [9][12]. Legislative Context - The Biden administration had previously pursued reclassification but did not implement changes before Trump left office [15]. - Various bills have been introduced in Congress to lower marijuana's classification or decriminalize it, but none have been signed into law [15]. Public Sentiment and Political Commentary - Senator Ron Wyden criticized Trump for misleading the public regarding the legality of marijuana, emphasizing that reclassification does not equate to decriminalization [10][11].